Doctors test tailored treatment to fight lymphoma while reducing harsh side effects
NCT ID NCT07209059
Summary
This study is testing a new, personalized approach to treating advanced Hodgkin lymphoma. It uses an early scan to see how well the initial treatment is working, then adjusts the follow-up therapy based on those results. The goal is to control the cancer effectively while trying to minimize long-term side effects for the 30 participants.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HODGKIN LYMPHOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
National Medical Research Center for Hematology
RECRUITINGMoscow, 125167, Russia
Contact Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.